Comparative lead
When you compare off-the-shelf COTS components against bespoke contract manufacturing, the decision hinges on verification effort just as much as cost. At Medtec China 2026 the conversation isn’t only about prices — it’s about whether your design passes IQ/OQ/PQ efficiently and reliably. Specifiers from Hong Kong to Shenzhen are watching how suppliers handle documentation, traceability and supplier change control before they commit.
Why COTS is tempting
COTS often means speed and known availability. For a design freeze with tight timelines, prequalified modules reduce design verification cycles and can simplify the installation qualification step. You get standard datasheets, defined manufacturing lots, and usually faster lead times — which helps when regulators expect clear device history records for ISO 13485 compliance. Still, COTS can force compromises on tolerances, sterilization methods, or software integration, so you must budget extra for operational qualification.
When custom contract manufacturing pays off
Custom builds let you optimise for performance, ergonomics and manufacturability from the beginning. If you need a specific material, bespoke tooling, or a unique firmware stack, custom suppliers fold those into the design transfer and validation plan. The trade-off: longer IQ/OQ/PQ timelines and tighter process validation. But when product differentiation matters —like battery life, sensor placement or patient contact materials—custom is often the only route to meet clinical requirements.
IQ — Installation Qualification
IQ confirms equipment and components are installed per supplier and regulatory requirements. Typical items to capture: serial numbers, environmental conditions at install, and calibration certificates. For COTS, include vendor certificates of conformance. For custom, record tooling setup and first-article inspection results to avoid later nonconformances.
OQ — Operational Qualification
OQ verifies the system operates across expected ranges. Document test protocols, pass/fail criteria and any firmware/hardware interactions. Include stress runs and edge-case cycles. A common flaw is inadequate test coverage for software-controlled subsystems — so run interface tests with the actual firmware build, not a simulation.
PQ — Performance Qualification
PQ demonstrates the device meets clinical use requirements under real-world conditions. Retention sample testing periods must be specified for sterilization and bioburden where applicable — for example, a 14-day bioburden incubation limit is typical for pre-release checks. Capture user scenarios, assembly variability and packaging effects that could influence performance over shelf life.
Common verification pitfalls
Many teams underestimate supplier change control and documentation depth. Missing revision-controlled drawings, incomplete traceability of components, or weak software versioning cause rework. Another frequent error: assuming COTS won’t require revalidation after a supplier part change. — Always define contractual triggers for requalification and maintain an approved vendor list.
Practical checklist for supplier selection
Use a short, actionable checklist during audits:- Proof of ISO 13485 certification and internal audit records.- Sample IQ/OQ/PQ protocols and historical evidence of execution.- Change control process with notification windows and risk assessment.- Lot traceability and retention sampling policies.Visit events like Medtec China to meet vendors and review real examples; seeing a factory run a validation sequence is worth the time.
Comparative insight summary
COTS shortens development but shifts work into integration and OQ. Custom reduces compromises but raises IQ and PQ effort. Consider total verification cost, not just unit price. Anchor your contract terms to verification milestones, and require supplier-provided validation evidence before accepting components into production — the paperwork matters as much as the parts.
Three golden rules for selecting the right strategy
1) Validation-to-cost ratio: choose the option where IQ/OQ/PQ cost plus expected rework stays below product margin thresholds. 2) Traceability robustness: demand full lot-level traceability and rapid supplier notification for changes. 3) End-use fidelity: prioritise the supplier who can reproduce clinical-use conditions during PQ, including packaging and storage stresses.
These three metrics cut through noise and let teams decide with clarity. Final thought — trust, but verify; and make verification contractually visible. Medtec. —
